Recommendations for screening and early detection of common cancers in India

The Lancet Oncology

Volumn 16, Issue 7, 2015, Pages e352-e361

  Rajaraman, Preetha ^a   Anderson, Benjamin O ^b   Basu, Partha ^c   Belinson, Jerome L ^d   D'Cruz, Anil ^e   Dhillon, Preet K ^f   Gupta, Prakash ^g   Jawahar, Tenkasi S ^h   Joshi, Niranjan ⁱ   Kailash, Uma ^j   Kapambwe, Sharon ^k   Katoch, Vishwa Mohan ^h   Krishnan, Suneeta ^l   Panda, Dharitri ^j   Sankaranarayanan, R ^m   Selvam, Jerard M ⁿ   Shah, Keerti V ^o   Shastri, Surendra ^e   Shridhar, Krithiga ^f   Siddiqi, Maqsood ^p   Sivaram, Sudha ^a   Seth, Tulika ^q   Srivastava, Anurag ^q   Trimble, Edward ^a   Mehrotra, Ravi ^j   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^d CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^e TATA MEMORIAL HOSPITAL   (India)

^f PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^g HEALIS SEKHSARIA INSTITUTE FOR PUBLIC HEALTH   (India)

^h INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

ⁱ INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^j INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

^k Centre for Infectious Disease Research   (Zambia)

^l RTI INTERNATIONAL   (United States)

^m INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

ⁿ Tamil Nadu Voluntary Health Association   (India)

^o JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^p Palliative Care Unit   (India)

^q ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; CANCER INCIDENCE; CANCER SCREENING; EARLY CANCER; EARLY DIAGNOSIS; ECHOMAMMOGRAPHY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; INDIA; LIP CANCER; MOUTH CANCER; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; REVIEW; SMOKING; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; BREAST NEOPLASMS; DEVELOPING COUNTRY; EVIDENCE BASED MEDICINE; FEMALE; LIP; MALE; MOUTH NEOPLASMS; PATHOLOGY; PRACTICE GUIDELINE; RISK ASSESSMENT; STANDARDS; UTERINE CERVICAL NEOPLASMS;

BREAST NEOPLASMS; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INDIA; LIP; MALE; MOUTH NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK ASSESSMENT; UTERINE CERVICAL NEOPLASMS;

EID: 84937431549     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00078-9     Document Type: Review

References (92)

1. Mortality and burden of disease estimates for WHO member states in 2012 WHO, (accessed June 5, 2015). http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html.
2. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0 Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 2012, International Agency for Research on Cancer, Lyon, France, (accessed Feb 24, 2015). http://globocan.iarc.fr%202013.
3. National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke 2010-11 Ministry of Health and Family Welfare, (accessed Feb 24, 2015). http://www.nhp.gov.in/node/179.
4. Mallath MK, Taylor DG, Badwe RA, et al. The growing burden of cancer in India: epidemiology and social context. Lancet Oncol 2014, 15:e205-e212.
5. Pramesh CS, Badwe RA, Borthakur BB, et al. Delivery of affordable and equitable cancer care in India. Lancet Oncol 2014, 15:e223-e233.
6. Sullivan R, Badwe RA, Rath GK, et al. Cancer research in India: national priorities, global results. Lancet Oncol 2014, 15:e213-e222.
7. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010, 11:165-173.
8. Sankaranarayanan R, Boffetta P Research on cancer prevention, detection and management in low- and medium-income countries. Ann Oncol 2010, 21:1935-1943.
9. Sankaranarayanan R Cancer prevention and care in India: an unfinished agenda. Lancet Oncol 2014, 15:554-555.
10. Schiffman M, Hildesheim A Cervical cancer. Cancer Epidemiology and Prevention 2006, Oxford University Press, New York. D. Schottenfeld, J.F. Fraumeni (Eds.).
11. Saxena U, Sauvaget C, Sankaranarayanan R Evidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low-resource countries: example of India. Asian Pac J Cancer Prev 2012, 13:1699-1703.
12. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 2008, 123:153-160.
13. Almonte M, Ferreccio C, Winkler JL, et al. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer 2007, 121:796-802.
14. Cuzick J, Bergeron C, von Knebel Doeberitz M, et al. New technologies and procedures for cervical cancer screening. Vaccine 2012, 30(suppl 5):F107-F116.
15. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009, 360:1385-1394.
16. Shastri SS, Mittra I, Mishra GA, et al. Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst 2014, 106:dju009.
17. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 2007, 370:398-406.
18. Mittra I, Mishra GA, Singh S, et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer 2010, 126:976-984.
19. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 2008, 111:167-177.
20. Eide ML, Debaque H HPV detection methods and genotyping techniques in screening for cervical cancer. Ann Pathol 2012, 32:e15-e23. 401-09.
21. Hoda RS, Loukeris K, Abdul-Karim FW Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences. Diagn Cytopathol 2013, 41:257-278.
22. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006, 119:1095-1101.
23. Comprehensive cervical cancer prevention and control-a healthier future for girls and women-WHO guidance note 2013, WHO, World Health Organization, Geneva.
24. Sankaranarayanan R, Nene BM, Dinshaw KA, et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer 2005, 116:617-623. the Osmanabad District Cervical Screening Study Group.
25. Yi X, Zou J, Xu J, et al. Development and validation of a new HPV genotyping assay based on next-generation sequencing. Am J Clin Pathol 2014, 141:796-804.
26. Gravitt PE, Belinson JL, Salmeron J, Shah KV Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer 2011, 129:517-527.
27. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev 2013, 2:35.
28. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005, 353:2158-2168. the Alliance for Cervical Cancer Prevention Cost Working Group.
29. Monitoring national cervical cancer prevention and control programmes: quality control and quality assurance for visual inspection with acetic acid (VIA)-based programmes 2013, WHO, World Health Organization, Geneva.
30. Three year report of Population Based Cancer Registries, 2009-2011 2013, Indian Council of Medical Research, National Centre for Disease Informatics and Research/National Cancer Registry Programme, Bangalore.
31. Gupta PC, Pednekar MS, Parkin DM, Sankaranarayanan R Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study. Int J Epidemiol 2005, 34:1395-1402.
32. Pednekar MS, Gupta PC, Yeole BB, Hébert JR Association of tobacco habits, including bidi smoking, with overall and site-specific cancer incidence: results from the Mumbai cohort study. Cancer Causes Control 2011, 22:859-868.
33. Radoï L, Luce D A review of risk factors for oral cavity cancer: the importance of a standardized case definition. Community Dent Oral Epidemiol 2013, 41:97-109. e78-91.
34. Guha N, Warnakulasuriya S, Vlaanderen J, Straif K Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control. Int J Cancer 2014, 135:1433-1443.
35. Muwonge R, Ramadas K, Sankila R, et al. Role of tobacco smoking, chewing and alcohol drinking in the risk of oral cancer in Trivandrum, India: a nested case-control design using incident cancer cases. Oral Oncol 2008, 44:446-454.
36. Dangi J, Kinnunen TH, Zavras AI Challenges in global improvement of oral cancer outcomes: findings from rural Northern India. Tobacco induced diseases 2012, 10:1-5.
37. Jayalekshmi PA, Gangadharan P, Akiba S, Koriyama C, Nair RR Oral cavity cancer risk in relation to tobacco chewing and bidi smoking among men in Karunagappally, Kerala, India: Karunagappally cohort study. Cancer Sci 2011, 102:460-467.
38. Znaor A, Brennan P, Gajalakshmi V, et al. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer 2003, 105:681-686.
39. Madani AH, Dikshit M, Bhaduri D Risk for oral cancer associated to smoking, smokeless and oral dip products. Indian J Public Health 2012, 56:57-60.
40. Jayalekshmi PA, Gangadharan P, Akiba S, Nair RR, Tsuji M, Rajan B Tobacco chewing and female oral cavity cancer risk in Karunagappally cohort, India. Br J Cancer 2009, 100:848-852.
41. Balaram P, Sridhar H, Rajkumar T, et al. Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 2002, 98:440-445.
42. Scully C Oral cancer aetiopathogenesis; past, present and future aspects. Med Oral Patol Oral Cir Bucal 2011, 16:e306-e311.
43. Combes JD, Franceschi S Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 2014, 50:370-379.
44. Global Tobacco Adults Survey Ministry of Health and Family Welfare, (accessed Feb 24, 2015). https://mohfw.nic.in/WriteReadData/l892s/1455618937GATS%20India.pdf.
45. Arnold F, Parasuraman S, Arokiasamy P, Kothari M Nutrition in India. National Family Health Survey. In: NFHS 3 I, 2005 06 Mumbai: International Institute for Population Sciences 2009, ICF Macro, Calverton.
46. Sankaranarayanan R, Ramadas K, Thara S, et al. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncol 2013, 49:314-321.
47. Gupta PC Mouth cancer in India: a new epidemic?. J Indian Med Assoc 1999, 97:370-373.
48. Anantha N, Nandakumar A, Vishwanath N, et al. Efficacy of an anti-tobacco community education program in India. Cancer Causes Control 1995, 6:119-129.
49. Mehta FS, Gupta PC, Pindborg JJ Chewing and smoking habits in relation to precancer and oral cancer. J Cancer Res Clin Oncol 1981, 99:35-39.
50. Gupta PC, Mehta FS, Daftary DK, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 1980, 8:283-333.
51. Napier SS, Speight PM Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008, 37:1-10.
52. Bhargava K, Smith LW, Mani NJ, Silverman S, Malaowalla AM, Bilimoria KF A follow up study of oral cancer and precancerous lesions in 57,518 industrial workers of Gujarat, India. Indian J Cancer 1975, 12:124-129.
53. Mehta FS, Shroff BC, Gupta PC, Daftary DK Oral leukoplakia in relation to tobacco habits. A ten-year follow-up study of Bombay policemen. Oral Surg Oral Med Oral Pathol 1972, 34:426-433.
54. Critchley JA, Unal B Health effects associated with smokeless tobacco: a systematic review. Thorax 2003, 58:435-443.
55. Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Mehta FS, Pindborg JJ An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer 1989, 63:2247-2252.
56. Mehta FS, Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Pindborg JJ Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev 1986, 9:219-225.
57. Gupta PC, Mehta FS, Pindborg JJ, et al. Intervention study for primary prevention of oral cancer among 36 000 Indian tobacco users. Lancet 1986, 1:1235-1239.
58. Gupta PC, Mehta FS, Pindborg JJ, et al. Primary prevention trial of oral cancer in india: a 10-year follow-up study. J Oral Pathol Med 1992, 21:433-439.
59. Brocklehurst P, Kujan O, Glenny AM, et al. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev 2010, 11. CD004150.
60. Subramanian S, Sankaranarayanan R, Bapat B, et al. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bull World Health Organ 2009, 87:200-206.
61. Mehrotra R, Gupta DK Exciting new advances in oral cancer diagnosis: avenues to early detection. Head Neck Oncol 2011, 3:33.
62. Fedele S Diagnostic aids in the screening of oral cancer. Head Neck Oncol 2009, 1:5.
63. Epstein JB, Scully C, Spinelli J Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 1992, 21:160-163.
64. Patton LL, Epstein JB, Kerr AR Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc 2008, 139:896-905.
65. Messadi DV Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci 2013, 5:59-65.
66. Mehrotra R, Mishra S, Singh M, Singh M The efficacy of oral brush biopsy with computer-assisted analysis in identifying precancerous and cancerous lesions. Head Neck Oncol 2011, 3:39.
67. Mehrotra R, Singh MK, Pandya S, Singh M The use of an oral brush biopsy without computer-assisted analysis in the evaluation of oral lesions: a study of 94 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 106:246-253.
68. Mehrotra R, Singh M, Thomas S, et al. A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc 2010, 141:151-156.
69. WHO Framework convention on tobacco control 2003, WHO, World Health Organisation, Geneva.
70. IARC Screening Group International Agency for Research on Cancer, (accessed June 5, 2015). http://screening.iarc.fr/trainingoral.php?lang=1.
71. Sankaranarayanan R, Ramadas K, Thara S, et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst 2011, 103:1476-1480.
72. Khokhar A Breast cancer in India: where do we stand and where do we go?. Asian Pac J Cancer Prev 2012, 13:4861-4866.
73. Harris JR, Lippman ME, Morrow M, Osborne CK Diseases of the breast 2014, Lippincott Williams and Wilkins, Philadelphia. 5th edn.
74. Breast cancer report: food, nutrition, physical activity, and the prevention of breast cancer World Cancer Research Fund and American Institute for Cancer Research, (accessed Feb 24, 2015). http://www.dietandcancerreport.org/expert_report/report_contents/index.php.
75. Yip CH, Smith RA, Anderson BO, et al. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer 2008, 113(suppl):2244-2256. the Breast Health Global Initiative Early Detection Panel.
76. Corbex M, Burton R, Sancho-Garnier H Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast 2012, 21:428-434.
77. Elmore JG, Armstrong K, Lehman CD, Fletcher SW Screening for breast cancer. JAMA 2005, 293:1245-1256.
78. Masood S, Vass L, Ibarra JA, et al. Breast pathology guideline implementation in low- and middle-income countries. Cancer 2008, 113(suppl):2297-2304. the Breast Health Global Initiative Pathology Focus Group.
79. Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst 2008, 100:1290-1300.
80. Bethesda M National Cancer Institute: PDQ breast cancer screening (accessed Feb 24, 2015). http://www.cancer.gov/cancertopics/pdq/screening/breast/healthprofessional.
81. Tsu VD, Jeronimo J, Anderson BO Why the time is right to tackle breast and cervical cancer in low-resource settings. Bull World Health Organ 2013, 91:683-690.
82. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Breast-cancer screening-viewpoint of the IARC Working Group. N Engl J Med 2015, published online June 3. 10.1056/NEJMsr1504363.
83. Lee T Comparison of breast cancer screening results in Korean middle-aged women: a hospital-based prospective cohort study. Osong Public Health Res Perspect 2013, 4:197-202.
84. Mo M, Liu GY, Zheng Y, et al. Performance of breast cancer screening methods and modality among Chinese women: a report from a society-based breast screening program (SBSP) in Shanghai. Springerplus 2013, 2:276.
85. Kolb TM, Lichy J, Newhouse JH Occult cancer in women with dense breasts: detection with screening US-diagnostic yield and tumor characteristics. Radiology 1998, 207:191-199.
86. Buchberger W, DeKoekkoek-Doll P, Springer P, Obrist P, Dünser M Incidental findings on sonography of the breast: clinical significance and diagnostic workup. AJR Am J Roentgenol 1999, 173:921-927.
87. Tsunoda-Shimizu H, Nakamura S Diagnostic assessment of nonpalpable breast cancer--the difference in diagnostic approach for the clinical treatment of breast cancer between the Japanese Guidelines and the National Comprehensive Cancer Network (USA) Guidelines. Breast Cancer 2005, 12:250-257.
88. Xiao Y, Zhou Q, Chen Z Automated breast volume scanning versus conventional ultrasound in breast cancer screening. Acad Radiol 2015, 22:387-399.
89. Brem RF, Lenihan MJ, Lieberman J, Torrente J Screening breast ultrasound: past, present, and future. AJR Am J Roentgenol 2015, 204:234-240.
90. Drukteinis JS, Mooney BP, Flowers CI, Gatenby RA Beyond mammography: new frontiers in breast cancer screening. Am J Med 2013, 126:472-479.
91. Irwig L, Houssami N, van Vliet C New technologies in screening for breast cancer: a systematic review of their accuracy. Br J Cancer 2004, 90:2118-2122.
92. El Saghir NS, Charara RN International screening and early detection of breast cancer: resource-sensitive, age- and risk-specific guidelines. Breast Cancer Manag 2014, 3:397-407.